Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing
January 22, 2015 07:04 ET
|
Selexis SA
GENEVA, Switzerland, Jan. 22, 2015 (GLOBE NEWSWIRE) -- via PRWEB - Selexis SA, a serial innovation company with proven technologies for characterized mammalian Research Cell Banks (RCBs) used for drug...
First Selexis SUREtechnology Generated Therapeutic Monoclonal Antibody Approved for Market
January 08, 2015 07:04 ET
|
Selexis SA
GENEVA, Switzerland, Jan. 8, 2015 (GLOBE NEWSWIRE) -- via PRWEB - Selexis SA, a serial innovation company with proven technologies for characterized mammalian Research Cell Banks used for drug...
Selexis SA's Marco Bocci Promoted to Vice President European Business Development
October 14, 2014 08:04 ET
|
Selexis SA
GENEVA, Switzerland, Oct. 14, 2014 (GLOBE NEWSWIRE) -- via PRWEB - Selexis SA, a serial innovation company with proven technologies for biologic drug discovery and mammalian cell line development, has...
Selexis SA to Present New Data and a Case Study at IBC's Cell Line Development and Engineering Conference
July 30, 2014 10:05 ET
|
Selexis SA
GENEVA, Switzerland, July 30, 2014 (GLOBE NEWSWIRE) -- via PRWEB - Selexis SA, a serial innovation company with proven technologies for biologic drug discovery and mammalian cell line development,...
Selexis SA to Showcase Revolutionary Advancements in Protein Expression Technologies at BIO 2014
June 05, 2014 08:33 ET
|
Selexis SA
GENEVA, Switzerland, June 5, 2014 (GLOBE NEWSWIRE) -- via PRWEB - Selexis SA, a serial innovation company with proven technologies for biologic drug discovery and mammalian cell line development,...
Selexis SA CEO to Speak at the BioProcess Theater at BIO 2014
May 30, 2014 10:34 ET
|
Selexis SA
GENEVA, Switzerland, May 30, 2014 (GLOBE NEWSWIRE) -- via PRWEB - Selexis SA, a serial innovation company with proven technologies for biologic drug discovery and mammalian cell line development...